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Drug Matrix cell E5: Treatment systems; Safeguarding the community
S  Seminal  studies  K  Key studies  R  Reviews  G  Guidance  MORE  Search for more studies
S  Proactive arrest referral  works  best ([UK] Home Office, 1999). Treatment entry and consequent crime reduction promoted
by proactively engaging arrestees  or offenders  in cel ls  and courts .
S  Lessons  of Cal i fornia’s  experience with compulsory treatment (1977). Lessons  of contemporary relevance from the
Cal i fornia  Civi l  Addict Program on how to integrate criminal  justice procedures  and voluntary and coerced treatment.
K  Retention maximises  treatment’s  crime-reduction impact ([UK] National  Treatment Agency for Substance Misuse, 2012).
Treatment systems which retain patients  maximal ly protect society from crime as  assessed by reconvictions.
K  Networking faci l i tates  evidence-based treatment practices  (2008). Suggests  that to improve uptake of evidence-based
practices  and qual i ty improvements , commiss ioners  should promote networking between several  agencies  providing criminal  justice treatment rather than
commiss ion a s ingle large organisation.
K  System changes  double post-release aftercare completion (2009). Promoting aftercare fol lowing release from a prison therapeutic community entai led
improvements  in offender involvement in pre-release planning, the aftercare funding system, staffing, cross-system training, and community support structures .
K  Systemic barriers  to employing problem drug users  ([UK] Department for Work and Pensions, 2010). Interviews with drug service cl ients  in Bri ta in and with staff
working in or with treatment agencies  highl ighted the need for greater integration between treatment services , the socia l  securi ty system, employment services  and
employers .
R  Non-coerced treatment associated with greatest crime reductions  (2008). Synthes is  of 129 studies  of offender treatment for problems including substance use
finds  treatment’s  crime-reducing impact increased to the degree to which the offender was  free to choose treatment. Impl ication is  that treatment systems should
make i t easy and attractive for problem drug users  to enter treatment without legal  coercion.
R  Treatment and criminal  justice integration (2003). Evidence-based thoughts  of eminent researcher on therapeutic criminal  justice interventions  for problem
drug use. Argues  for blending treatment and criminal  justice sanctions/supervis ion to match the type of offender, and identi fies  four elements  of successful
programmes. See also this  academic and ful ly referenced vers ion.
R  Melding disparate objectives  and cultures  is  key to criminal  justice treatment (Austral ian Government, 2005). Real istical ly acknowledges  (section headed
“Providing AOD treatment within the context of the criminal  justice system”) that criminal  justice and treatment have di fferent objectives  and phi losophies  and
don’t natural ly see eye to eye, but argues  that education and training can underpin col laboration to achieve shared goals .
R  Organise continuity of care to make most of opioid maintenance in prison (2011). Continuity of treatment from before to during and after prison is  the key to
gaining benefi ts  s imi lar to those in seen in community settings .
G  Commiss ioning for recovery in the community and prisons  ([UK] National  Treatment Agency for Substance Misuse, 2010). Cal ls  for commiss ioners  to repl icate
“as  appropriate” in prisons  a  balanced, recovery-focused treatment system with access  to community-based and res identia l  treatment, and ongoing mutual  a id
support.
G  Reducing drug-related crime and rehabi l i tating offenders  (2010). Government-supported Engl ish expert group recommends commiss ioning and coordination
measures  to improve outcomes without extra resources.
G  Cl inical  governance in drug treatment ([UK] National  Treatment Agency for Substance Misuse, 2009). Guidance for providers  and commiss ioners  on systems to
del iver and demonstrate that the qual i ty and safety of services  are of a  high standard and continual ly improving; includes  prison- and community-based criminal
justice interventions.
G  The roles  of substance use services  in systems to safeguard chi ldren ([UK] Advisory Counci l  on the Misuse of Drugs, 2003). Results  of an inquiry in to chi ldren in
the UK serious ly affected by the drug use of parents  or guardians. Includes  (starting p. 71) guidance on how drug treatment and other services  can act together in
the best interests  of the chi ldren. Update publ ished in 2006 documents  (from p. 44) the degree to which such systems had been establ ished.
G  Protocol  for joint working between drug/alcohol  services  and chi ldren/fami ly services  ([UK] National  Treatment Agency for Substance Misuse, 2011). Intended
to help local  areas  develop agreements  to strengthen the relationship between these services  in order to safeguard the chi ldren of substance users . Includes
identi fication, assessment and referral , sharing information, and staff competencies  and training.
G  Whole-fami ly recovery advocated in Scotland (Scottish Government, 2013). Guidance speci fic to substance use intended for a l l  chi ld and adult services ,
including drug and alcohol  services . What new patients  should be asked about chi ldren and the role these services  should play in a  system which (“Getting our
Priori ties  Right” is  the ti tle) priori tises  chi ld welfare.
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What is this cell about? Constructing local, regional or national systems featuring treatment (usually along with criminal justice
procedures) for offenders whose offending is to some extent driven by their drug use, typically in the form of acquisitive crime to fund
drug purchases in illegal markets. In these contexts, treatment is offered or imposed not because it has been sought by the client, but
because it is thought that treating their substance use problems could reduce crime or otherwise benefit the community. Also includes
other such systems which benefit the community by identifying and/or responding to problem drug use, including protecting the user’s
children and reducing economic impacts due for example to unemployment. As with commissioning in general, involves organising
treatment provision to meet population needs in the context of resource constraints and national policy.
Research on treatment systems is rarely of the ‘gold-standard’, randomised controlled trial format. Whole areas and multiple
coordinating agencies cannot easily be randomly assigned to implement experimental systems of care, while others must stand still or do
the conventional thing to form a comparator; communities have their own lives, politics and event-driven diversions beyond the
researcher’s control. Instead, researchers usually look for patterns in what naturally happens rather than manipulating it to test the
consequences; all this cell’s key studies used variants on this methodology. Those patterns may reflect the presumed cause and effect
mechanisms, but they may instead reflect unmeasured variables which randomisation would have eliminated from the effectiveness
equation.
Treatment systems developed for criminal justice purposes are often derived from those centred on patient welfare and the overcoming
of dependence. The impact of treatment in general on crime is the reason why it was adopted for criminal justice purposes. This means
that for more research and ideas and we refer you back to cells dealing with treatment systems generally, with medical treatments, and
with psychosocial therapies.
SEND
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Where should I start? Combining the precepts of our two starting points would afford planners a good chance of giving birth to a
successful treatment/criminal justice programme for drug-driven offenders. First is from Professor Douglas Marlowe, the US researcher
whose work on matching such programmes to the characteristics of the offender was highlighted in cell C5’s bite. In two freely available
reviews he has distilled the implications for programme planners of his own and other research and experience, one an academic
presentation, the other more practitioner-friendly.
He argues that rather than one or the other, programmes which blend criminal justice and drug treatment functions offer the chance to
systematically adjust the mix according to the offender, some of whom do best simply being diverted into treatment, while others require
intensive monitoring by criminal justice authorities and consistent sanctions/rewards to ensure they engage with treatment. Look in the
practitioner-friendly version at the panel headed “Elements of Successful Programs”. It lists what Professor Marlowe judges to be “core
... attributes” shared by the most demonstratively effective of these programmes: They take place in the community rather than in prison;
offer the reward of avoiding a criminal record or imprisonment; have the authority to make revoking criminal justice sanctions contingent
on treatment completion and abstinence; can closely supervise offenders via (among other means) urinalyses and reports from clinicians
treating the offender; and can quickly levy set sanctions and rewards without having to hold new formal hearings. Not all these elements
will be needed for every offender, but they should be available if from the start they seem to require them, or if their progress (or lack of
it) suggests they are needed.
Second starting point is a review co-published by the Australian government. Its contribution is to summarise what it will take for criminal
justice and treatment systems to work together to offer the effective programmes described by Professor Marlowe. Turn to page 10 and
you will see a bulleted list which distils US guidance down to nine requisites for joint working between systems which “can see the other
as ill-informed, unrealistic and undermining”. The following pages expand on the elements of the list, ending on page 12 by explaining
that these come to a head in the case management function, which entails orchestrating services for the offender throughout their
sentence/treatment. Doing this collaboratively “assumes that the criminal justice worker and the treatment provider view themselves as
partners in a common effort to get the client-offender in recovery from [alcohol and other drug] abuse and living a crime-free life”.
ISSUES TO THINK ABOUT
 How far should collaboration go? Note again that last quote from the Australian starting point review: coordinating treatment in a
criminal justice context “assumes that the criminal justice worker and the treatment provider view themselves as partners in a common
effort to get the client-offender in recovery from [alcohol and other drug] abuse and living a crime-free life”. From that starting point,
says the review, these partners “can co-operate in setting goals for the client-offender, responding to undesirable or order-violating
behaviour, and adjusting the terms of probation or parole and/or the type and intensity of treatment.” Elsewhere the same document
says collaborative working relationships mean responses to issues such as relapse will be “based on trying to achieve common goals for
the client-offender,” which in turn means “the criminal justice system is much more likely to trust clinicians to make decisions and
treatment personnel are more likely to base their decision on clinical grounds with full consideration of security and public safety”.
“Full consideration” and “common goals” imply a collaboration so deep that what started out as the disparate goals identified in the
review eventually become one. Given that the power in this collaboration lies mainly with the criminal justice system, which must enforce
the goals of the sentence, can require reports from the treatment service, and can revoke or change treatment, do the shared goals
become in practice those of the criminal justice system? That seems to be the view of a US expert whose manual on criminal justice
supervision was listed in cell D5. More directly than the Australian review cited above, she sees (p. 69) a good relationship between
criminal justice staff and treatment services as enabling them to “work together toward the goal of maximum recidivism reduction”.
Treatment services “must address criminogenic needs” which may include substance abuse, but not concern themselves with “non-
criminogenic factors, such as anxiety and low self-esteem” which “do not contribute to the mission of recidivism reduction”.
Is this type of crime-centred collaboration desirable, or will it ‘kill the goose that lays the golden egg’ – robbing treatment of its focus on
the patient’s welfare, and with that its ability to engender crime-reducing change? In the US starting point review, Professor Marlowe
alters the emphasis somewhat. Here’s what he says in the academic version: that despite advocating integration, “responsibility for
ensuring offenders’ adherence to treatment and avoidance of drug use and criminal activity is not, however, delegated to treatment
personnel who may be unprepared or disinclined to deal with such matters and who may have very limited power to intervene.” It is, in
other words, not the treatment service’s job to make sure the offender does not return to crime; that degree of sharing of goals is
explicitly ruled out. Presumably, it is primarily their job to ‘treat’ their client or patient – though he says services should also cooperate
with the authority ordering or commissioning the treatment, for example, by providing regular progress reports and testimony at hearings.
Where these issues come to a head is in rules about confidentiality – what the treatment service will/must disclose to criminal justice
officers about the offender and what they have said or done during treatment. The Australian review deals with this on page 14, the US
review in the panel headed “Confidentiality Guidelines for Integrated Approaches”. Can you discern any substantive differences between
the two?
 Is coercion a good thing? At the level of an individual dependent on drugs, the answer we have learnt is that it depends on their
characteristics and how they react to the initial programme. But the question being asked in this cell is set at the level of a whole local
area, regional or national treatment system – whether it should be set up to maximise the degree and extent of coercion, or focus on
making treatment so accessible, welcoming and non-stigmatised, that formal criminal justice coercion is the exception.
Cell D5’s bite recounted what has become the conventional understanding of the role of criminal justice coercion in treatment – that it
“has the tools and the authority to ‘hold’ problem drug users in treatment long enough and get them to ‘work the programme’ diligently
enough to gain benefits”. US authorities are definite that “Individuals under legal coercion tend to stay in treatment longer and do as well
as or better than those not under legal pressure.” This assertion is not without research support, but findings are inconsistent: sometimes
things go better for legally coerced treatment entrants, sometimes worse, sometimes about the same, and few studies could locate a
comparison group comparable enough to be sure the findings were due only to the absence versus presence of formal coercion, rather
than to differences in the types of patients who are coerced or not, or in the treatments they receive.
One way to gain an impression of the potential impact of coercion is to pool the results of these studies, affording an estimate of the
association between coercion and crime reduction. To the degree to which the biases of the studies balance out, this might also be an
estimate of the cause-and-effect impact of adding coercion to the treatment mix. Such a synthesis was conducted on 129 studies which
compared the recidivism of groups of offenders under different degrees of legal pressure to enter treatment; in nearly 4 in 10 of the
studies, the treatment addressed substance use. The analysis improved on prior attempts by categorising pressure on a five-point scale
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from mandatory through descending degrees of coercion to voluntary, and by separating studies in to those where offenders were in
custody, versus those where they were being supervised and treated outside prison.
Read our analysis and you will see that as the degree of voluntariness increased, so too did the treatment programme’s crime-reduction
impact relative to the comparator. While recognising its limitations, the authors said their analysis “challenges a number of studies that
concluded mandated treatment is effective and superior to nonmandated or voluntary treatment in outcome and retention.” Since “It
appears that some element of coercion may adversely affect the outcome of voluntary treatment,” they called for “Further research ... on
methods of motivating offenders to attend treatment on their own and/or increasing choice and reward for attending treatment.”
These findings and these conclusions argue (as in respect of alcohol treatment, did Project MATCH researchers) for there to be easily
accessible and appealing doors to treatment of as many different kinds as are needed to attract different kinds of drug-driven offenders
to enter without formal coercion. Along the way they offer support for Professor Marlowe’s contention (see above, Where should I start?)
that the most effective programmes take place in the community rather than in prison. In the community, voluntary programme entry still
does most to reduce crime, but coerced treatment entry also helps.
Before you accept the implications of these findings, check the caveats in our commentary. Among the most concerning is that treatment
volunteers may simply be more motivated to overcome their substance use problems with this their criminal careers. Perhaps equally
motivated offenders formally coerced in to treatment would do just as well, but are simply fewer in number – otherwise they would have
sought treatment on their own initiatives. On the other hand, the availability of non-stigmatised, easy-access and attractive treatment
options is not necessarily divorced from motivation. Perhaps having these possibilities open to you makes you more motivated to
overcome your problems because they offer the hope of an attainably better life; good voluntary treatment options may help create
motivation. Perhaps too, feeling oneself forced in to treatment, the nature of which you cannot choose, could undermine whatever
motivation was there in the first place.
Whatever your views on these issues, the featured analysis throws in to question what have become conventional evidence-based
assumptions about the equality or superiority of legally coerced treatment, tending to support common-sense understandings that what
one freely chooses to commit to is more likely to engage one and have the desired effect. The caveats mean however that the question is
not yet answered either way, and cannot be until we have a set of studies which randomly allocated offenders to different degrees of
coercion while equalising every other element which might affect outcomes.
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